
Co-Diagnostics (CODX) Earnings Dates & Reports
Co-Diagnostics (CODX) Most Recent Earnings
Report Date
Period EndingQ2 2026
Est. EPS-$3
Actual EPS-$1.46
EarningsBeat
Co-Diagnostics (CODX) Earnings
View the latest Co-Diagnostics (CODX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Co-Diagnostics (CODX)
Order type
Buy in
Order amount
Est. shares
0 shares
Co-Diagnostics (CODX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Co-Diagnostics (CODX) Latest Earnings
The value each CODX share was expected to gain vs. the value each share gained.
Co-Diagnostics (CODX) reported its most recent earnings on for Q2 2026, posting earnings per share (EPS) of -$1.46. This exceeded analysts' expectations of -$3 by 51.33%, marking a Beat.
For comparison, Co-Diagnostics reported EPS of -$6.90 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$2.40.
Co-Diagnostics (CODX) Earnings History
Co-Diagnostics (CODX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Co-Diagnostics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Co-Diagnostics (CODX) Earnings FAQs
Co-Diagnostics (CODX) last reported earnings on Aug 13, 2026 for Q2 2026, posting an EPS of -$1.46, which Beat the estimate of -$3 by 51.33%.
For Q2 2026, Co-Diagnostics (CODX) reported an EPS of -$1.46, exceeding analysts' estimate of -$3 by 51.33%.
For Q2 2026, Co-Diagnostics (CODX) Beat expectations with an actual EPS of -$1.46 vs. an estimated EPS of -$3.
Following the last earnings report on Aug 13, 2026, Co-Diagnostics (CODX)'s stock price moved — from — to —.
The next Co-Diagnostics (CODX) earnings call is scheduled for Nov. 12, 2026, where executives will discuss financial results and outlook.